A pooled analysis of 1,298 ME/CFS patients from eight trials revealed that CBT was associated with significant reductions in fatigue severity and functional impairment, alongside improvements in physical function [160]
Semaglutide is a type of chemical known as a GLP-1 agonist, and physicians and outsourcing facilities were previously allowed to make and distribute compounded, off-brand versions of semaglutide products due to shortages
Research suggests it may increase endogenous GLP-1 secretion from intestinal L-cells, providing a mild GLP-1 boosting effect that complements rather than replaces exogenous GLP-1 therapy
Avoid using areas with wounds
The FDA has further stated that Retatrutide cannot be used in compounding under federal law, as it is not a component of an FDA-approved drug [4]
Some patients can develop lymphatic dysfunction causing lymphedema